About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
COLL - Collegium Pharmaceut...| Previous Close | $22.41 | Open | $22.37 |
| Volume | 16.2K | Market Cap | 385.78M |
| Yield | Last Dividend |
| Collegium Pharmaceutical Earnings Scorec... | 02/24/21 |
| Collegium Pharmaceutical announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by... | |
| Collegium to Host Conference Call to Dis... | 02/11/21 |
| STOUGHTON, Mass., Feb. 11, 2021 -- Collegium Pharmaceutical, Inc. announced today that the Company will host a conference call and live audio webcast ... | |
| The Daily Biotech Pulse: DermTech Soars ... | 02/11/21 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 11) 10X... | |
| The Daily Biotech Pulse: Lilly COVID-19 ... | 02/10/21 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 10) 9 M... | |
| The Daily Biotech Pulse: Decision Day Fo... | 01/28/21 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 27) Abb... | |
| Zacks: Brokerages Expect Collegium Pharm... | 10/24/20 |
| Wall Street brokerages expect Collegium Pharmaceutical Inc (NASDAQ:COLL) to report sales of $77.92 million for the current quarter, according to Zacks... | |
| Collegium Pharmaceutical (NASDAQ:COLL) S... | 10/24/20 |
| Collegium Pharmaceutical (NASDAQ:COLL) was downgraded by BidaskClub from a ???buy??? rating to a ???hold??? rating in a research note issued on Thursd... | |
| Collegium to Host Conference Call to Dis... | 10/22/20 |
| STOUGHTON, Mass., Oct. 22, 2020 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) announced today that the Company will host a confere... | |
| Hedge Funds Keep Buying Collegium Pharma... | 06/19/20 |
| The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.... | |
| Collegium Pharmaceutical (COLL) Earnings... | 04/30/20 |
| Collegium Pharmaceutical (COLL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Ge... | |
| Stock To Watch: Collegium Pharmaceutical... | 02/12/20 |
| Collegium Pharmaceutical Inc. (COLL) is currently trading at $23.28, an increase of 4.82 percent from the previous closing price of $22.82.. | |
| The Daily Biotech Pulse: Novo Nordisk's ... | 01/17/20 |
| The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs o... | |
| The Daily Biotech Pulse: Positive Data R... | 01/10/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 9) A... | |
| The Daily Biotech Pulse: Merck's Keytrud... | 01/09/20 |
| The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs o... | |
| The Daily Biotech Pulse: Tonix Says No S... | 11/27/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Nov. 26) ... | |
| The Daily Biotech Pulse: ChemoCentryx Tr... | 11/26/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs on Nov. 25.... | |
| The Daily Biotech Pulse: Therapix Calls ... | 11/08/19 |
| The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs N... | |
| Collegium Pharmaceutical (COLL) Q2 Earni... | 08/07/19 |
| Collegium Pharmaceutical (COLL) delivered earnings and revenue surprises of 152.63% and -1.31%, respectively, for the quarter ended June 2019. Do the ... | |
| Earnings Preview: Collegium Pharmaceutic... | 07/31/19 |
| Collegium Pharmaceutical (COLL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Ge... | |
| The Daily Biotech Pulse: Vertex Bets Big... | 06/07/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on June 6) B... | |
| The Daily Biotech Pulse: Takeda Pulls Pl... | 06/06/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on June 5) A... | |
| The Daily Biotech Pulse: Curtains Down O... | 06/05/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on June 4) A... | |
| The Daily Biotech Pulse: Tocagen Tumbles... | 05/22/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs on May 21) A... | |
| Collegium Pharmaceutical, Inc. (COLL) Q1... | 05/09/19 |
| COLL earnings call for the period ending March 31, 2019. | |
| Collegium Pharmaceutical, Inc. (COLL) CE... | 05/08/19 |
| Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q1 2019 Earnings Conference Call May 8, 2019, 04:30 PM ET Company Participants Alex Dasalla - Head, IR Jo... | |
| Collegium Pharmaceutical (COLL) Reports ... | 05/08/19 |
| Collegium Pharmaceutical (COLL) delivered earnings and revenue surprises of 83.33% and 6.29%, respectively, for the quarter ended March 2019. Do the n... | |
| Collegium Pharmaceutical misses by $0.01... | 05/08/19 |
| No summary available. | |
| Collegium Pharmaceutical Q1 Earnings Pre... | 05/07/19 |
| No summary available. | |
| Collegium Pharmaceutical (COLL) Expected... | 05/01/19 |
| Collegium Pharmaceutical (COLL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prep... | |
| Collegium Pharmaceutical (COLL) Upgraded... | 03/25/19 |
| Collegium Pharmaceutical (COLL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank ... | |
| Buy rating | 01/11/21 |
| HC Wainwright & Co. maintains Buy rating and raises Price Target from $29.00 to $33.00 | |
| Date | 2021-02-25 (AMC) | Est. (EPS/Rev.) | $0.29/ 77.41M |
| Actual (EPS/Rev.) | $0.20/ $76.27 M | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Jess Corner | Jess | 79.00 % | Follow |
| Arbitrage Trade Analytics | Royce Wells | 72.00 % | Subscribe |
| Alpha Swing Trades | Jonathan | 68.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
